Skip to content
PICO Portalanswers from OpenAlex

Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China

PaperCitations, authors & open-access status

Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China is a paper indexed in PICO Portal from OpenAlex.

How many citations does Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China have?

PICO Portalcitation count

Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China has 64 citations in the OpenAlex counts PICO Portal stores.

When was Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China published?

PICO Portalyear

Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China has 2021 year in the PICO Portal index.

What is the open-access status of Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China?

PICO Portaloa status

Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China has green oa status in the PICO Portal index.

What is the DOI of Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China?

PICO Portaldoi

The DOI for Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China is on the source record.

What is the PMID of Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China?

PICO Portalpmid

The PMID for Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China is on the source record.

What is the OpenAlex record for Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China?

PICO Portalopenalex

The OpenAlex for Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial